NCT00193284View on ClinicalTrials.gov

Chemotherapy Plus Gefitinib Followed by Chemotherapy, Radiation Therapy, and Gefitinib For Head and Neck Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

October 31, 2003

Primary Completion Date

February 28, 2006

Study Completion Date

January 31, 2009

Conditions
Head and Neck Cancer
Interventions
DRUG

Gefitinib

DRUG

Docetaxel

DRUG

Carboplatin

DRUG

Fluorouracil

Trial Locations (1)

37023

Tennessee Oncology, PLLC, Nashville

Sponsors
All Listed Sponsors
collaborator

AstraZeneca

INDUSTRY

collaborator

Aventis Pharmaceuticals

INDUSTRY

lead

SCRI Development Innovations, LLC

OTHER